Can we improve our understanding of cardiovascular disease (CVD) causality and prediction? Intuitively, we can. Recent publications, however, could be misinterpreted as suggesting the opposite. First, the Interheart study, which concluded that nine conventional risk factors explain >90% of premature myocardial infarction, is at risk for being interpreted as saying that other, 'new' cardiovascular risk factors can only cause a small remaining fraction of disease of at most 10%. Secondly, papers addressing the predictive value of new risk factors or markers of early CVD risk have concluded that risk prediction does not improve by adding these variables to risk models. In this paper, we will explain that searching for 'new causes' of CVD is st...
Aims: Averaged measurements, but not the progression based on multiple assessments of carotid intima...
Purpose of Review This review discusses the recent evidence for a selection of blood-based emerging ...
Risk factors are important in cardiovascular (CV) medicine for risk stratification of patients. We a...
See page 441 for the editorial comment on this article (doi:10.1093/eurheartj/ehm644) Can we improve...
Background: Although the National Vascular Disease Prevention Alliance (NVDPA) guidelines were publi...
New cardiovascular risk determinants do exist and are clinically useful I read with interest the art...
An over-abundance of risk models offering few real benefits to patients Emerging as a leading cause...
Introduction Prediction of coronary heart disease (CHD) is based on multivariable risk equations de...
New cardiovascular risk determinants do exist and are clinically useful I read with interest the art...
Cardiovascular disease (CVD) is estimated to be the leading cause of death and disability-adjusted l...
Discovery of novel biomarkers and improvement of risk predic-tion algorithms will be a key to fulfil...
Over the past few decades, a number of coronary artery disease (CAD) and cardiovascular disease (CVD...
Cardiovascular disease (CVD) remains a leading cause ofmorbidity and mortality worldwide, including ...
This study challenges conventional wisdom that patients with more coronary heart disease (CHD) risk ...
D espite several decades of innovative research that has elucidated behavioral and biologi-cal risk ...
Aims: Averaged measurements, but not the progression based on multiple assessments of carotid intima...
Purpose of Review This review discusses the recent evidence for a selection of blood-based emerging ...
Risk factors are important in cardiovascular (CV) medicine for risk stratification of patients. We a...
See page 441 for the editorial comment on this article (doi:10.1093/eurheartj/ehm644) Can we improve...
Background: Although the National Vascular Disease Prevention Alliance (NVDPA) guidelines were publi...
New cardiovascular risk determinants do exist and are clinically useful I read with interest the art...
An over-abundance of risk models offering few real benefits to patients Emerging as a leading cause...
Introduction Prediction of coronary heart disease (CHD) is based on multivariable risk equations de...
New cardiovascular risk determinants do exist and are clinically useful I read with interest the art...
Cardiovascular disease (CVD) is estimated to be the leading cause of death and disability-adjusted l...
Discovery of novel biomarkers and improvement of risk predic-tion algorithms will be a key to fulfil...
Over the past few decades, a number of coronary artery disease (CAD) and cardiovascular disease (CVD...
Cardiovascular disease (CVD) remains a leading cause ofmorbidity and mortality worldwide, including ...
This study challenges conventional wisdom that patients with more coronary heart disease (CHD) risk ...
D espite several decades of innovative research that has elucidated behavioral and biologi-cal risk ...
Aims: Averaged measurements, but not the progression based on multiple assessments of carotid intima...
Purpose of Review This review discusses the recent evidence for a selection of blood-based emerging ...
Risk factors are important in cardiovascular (CV) medicine for risk stratification of patients. We a...